Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 18.58
-0.02 (-0.11%)
Apr 24, 2026, 3:14 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 14.39 billion as of April 24, 2026. Its market cap has decreased by -28.98% in one year.
Market Cap
14.39B
Enterprise Value
13.33B
Revenue
2.04B
Ranking
n/a
PE Ratio
29.52
Stock Price
18.58
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 14.39B, an increase of 124.58%. That is a compound annual growth rate of 8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 14.40B | -5.44% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Double Medical Technology | 18.12B |
| Shandong Weigao Blood Purification Products | 15.64B |
| MeHow Innovative | 15.41B |
| Beijing Balance Medical Technology | 14.16B |
| Shanghai MicroPort Endovascular MedTech | 12.07B |
| Shandong Weigao Orthopaedic Device | 12.00B |
| SonoScape Medical | 11.97B |
| Shanghai MicroPort EP MedTech | 11.37B |